Miguel Lorenzo

ORCID: 0000-0001-9182-4459
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Potassium and Related Disorders
  • Blood Pressure and Hypertension Studies
  • Cardiac Structural Anomalies and Repair
  • Advanced MRI Techniques and Applications
  • Cardiac Valve Diseases and Treatments
  • Mechanical Circulatory Support Devices
  • Cardiac pacing and defibrillation studies
  • Cardiac Health and Mental Health
  • Cardiovascular and exercise physiology
  • Erythropoietin and Anemia Treatment
  • Hemodynamic Monitoring and Therapy
  • Infective Endocarditis Diagnosis and Management
  • Pulmonary Hypertension Research and Treatments
  • Geographic Information Systems Studies
  • Dialysis and Renal Disease Management
  • Cardiac Arrhythmias and Treatments
  • Acute Myocardial Infarction Research
  • Emergency and Acute Care Studies
  • Heart rate and cardiovascular health
  • Membrane-based Ion Separation Techniques
  • Cardiovascular Effects of Exercise

Hospital Clínico Universitario de Valencia
2020-2025

Universitat de València
2020-2025

Centro de Investigación en Red en Enfermedades Cardiovasculares
2025

INCLIVA Health Research Institute
2023-2024

GTx (United States)
2021

Navarro College
2021

Centro de Investigación y Tecnología Agroalimentaria de Aragón
2021

Universidad de Zaragoza
2021

Institute of Cardiology
2020

Complejo Hospitalario Torrecárdenas
2012

Javier Bermejo Raquel Yotti Rocío García‐Orta Pedro L. Sánchez Mario Castaño and 93 more Javier Segovia Pilar Escribano Subías José Alberto San Román Xavier Borrás Joaquín Alonso Javier Botas María G. Crespo‐Leiro Sonia Velasco Antoni Bayés‐Genís Amador López Roberto Muñoz‐Aguilera Eduardo de Teresa José Ramón González–Juanatey Arturo Evangelista Teresa Mombiela Ana González‐Mansilla Jaime Elı́zaga Javier Martín‐Moreiras José María González‐Santos Eduardo Moreno Escobar Francisco Fernández‐Avilés Javier Bermejo Raquel Yotti Teresa Mombiela Ana González‐Mansilla Jaime Elı́zaga José Antonio García-Robles Esther Pérez David Candelas Pérez del Villar Ricardo Sanz Enrique Gutiérrez María Eugenia Vázquez Ana Mur Yolanda Benito Pablo Martínez‐Legazpi Alicia Gómez‐Barrio Alexandra Vázquez Rocío García‐Orta Inés Uribe Mercedes Freire González Pedro L. Sánchez José María González‐Santos Javier Martín‐Moreiras Antonio Arribas Miguel Lorenzo Alejandro Diego Nieto Mario Castaño Armando Pérez de Prado David Alonso‐Gutiérrez Javier Segovia Manuel Gómez‐Bueno Inés Sayago Silva Miguel Ángel Broc Cavero Pilar Escribano Subías Laura Domínguez Rocío Tello de Meneses María José Caño Carmen Jiménez López-Guarch José Alberto San Román Pedro Mota Xavier Borrás Carmen Amorós Galitó Joaquín Alonso María C. Mora Dolores Mesa Javier Botas Raquel Campuzano María G. Crespo‐Leiro Raquel Marzoa José Cuenca Sonia Velasco Roberto Muñóz Verónica Suberviola Cristina Beltrán Herrera Laura Mora M Sarrión David Vaqueriza Antoni Bayés‐Genís Elena Ferrer José Ramón González–Juanatey Belén Cid A. Martínez Monzonís Amador López José M Arizón de Prado Marta Santisteban Dolores Mesa Arturo Evangelista David García‐Dorado Eduardo de Teresa Manuel F. Jiménez‐Navarro Fernando Carrasco Chinchilla Eduardo Moreno Escobar Joaquín Alonso

We aimed to determine whether treatment with sildenafil improves outcomes of patients persistent pulmonary hypertension (PH) after correction valvular heart disease (VHD).

10.1093/eurheartj/ehx700 article EN cc-by-nc European Heart Journal 2017-11-14

Intrarenal venous flow (IRVF) measured by Doppler ultrasound has gained interest as a potential surrogate marker of renal congestion and adverse outcomes in heart failure. In this work, we aimed to determine if antigen carbohydrate 125 (CA125) plasma amino-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with congestive IRVF patterns (i.e., biphasic monophasic) acute failure (AHF).We prospectively enrolled consecutive cohort 70 patients hospitalized for AHF. Renal was...

10.1093/ehjacc/zuab022 article EN European Heart Journal Acute Cardiovascular Care 2021-03-19

Mineralocorticoid receptor antagonists (MRA) improve outcomes in patients with heart failure and reduced ejection fraction (HFrEF) but are underused clinical practice. Observational data suggest that hyperkalemia is the leading obstacle for suboptimal use of MRA.

10.1016/j.jacc.2024.11.014 article EN cc-by-nc-nd Journal of the American College of Cardiology 2024-11-01

Introduction: Antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload and inflammation in acute heart failure (AHF). We aimed to evaluate the influence dapagliflozin on CA125 levels within first weeks after discharge whether changes were related 6-month adverse clinical outcomes. Methods: In this retrospective observational study, data from 956 AHF patients discharged tertiary hospital analyzed. assessed during index admission (visit 1) at median 26 (15-39) days 2). The...

10.1159/000543417 article EN cc-by-nc Cardiorenal Medicine 2025-01-08

The impact of sex in patients with CAD has been widely reported, but little is known about the influence on risk new-onset HF or suspected CAD. We aimed to examine sex-related differences and heart failure (HF) coronary artery disease (CAD) undergoing vasodilator stress cardiac magnetic resonance (CMR).We prospectively evaluated 5899 consecutive HF-free submitted CMR for Ischaemic burden (number segments stress-induced perfusion deficit) left ventricular ejection fraction (LVEF) were...

10.1093/eurjpc/zwab078 article EN European Journal of Preventive Cardiology 2021-04-27

Background Following a heart failure (HF)‐decompensation, there is scarce data about sex‐related prognostic differences across left ventricular ejection fraction (LVEF) status. We sought to evaluate in 6‐month mortality risk LVEF following admission for acute HF. Methods and Results retrospectively evaluated 4812 patients consecutively admitted HF multicenter registry from 3 hospitals. Study end points were all‐cause, cardiovascular, HF‐related at follow‐up. Multivariable Cox regression...

10.1161/jaha.121.022404 article EN cc-by-nc-nd Journal of the American Heart Association 2021-12-20

Abstract We aimed to assess the association between CA125 and long-term risk of total acute heart failure (AHF) admissions in patients with an index hospitalization AHF preserved ejection fraction (HFpEF). prospectively included 2369 2008 2019 three centers. NT-proBNP were measured during early evaluated as continuous categorized quartiles (Q). Negative binomial regressions used recurrent admission. The mean age sample was 76.7 ± 9.5 years 1443 (60.9%) women. Median values 38.3 (19.0–90.0)...

10.1038/s41598-022-05328-2 article EN cc-by Scientific Reports 2022-01-25

Background The clinical impact of heart rate (HR) in failure with preserved ejection fraction (HFpEF) is a matter debate. Among those HFpEF, chronotropic incompetence (CI) has emerged as pathophysiological mechanism linked to the severity disease. In this study, we sought evaluate whether admission acute differs along left ventricular (LVEF).

10.1080/14017431.2024.2386977 article EN cc-by-nc Scandinavian Cardiovascular Journal 2024-08-08

Ovine anaplasmosis is a vector-borne disease caused by Anaplasma ovis and mainly transmitted through tick bites. In Spain, the first outbreak of ovine occurred in 2014. An epidemiological study fifty-one farms was carried out associated with this affected geographical area. questionnaire performed. addition, whole blood samples were taken for molecular analysis 47 these to determine prevalence infection ovis. A. present 44 PCR-analysed (93.6%). However, only 40.4% studied showed severe...

10.3390/ani11072036 article EN cc-by Animals 2021-07-08

Abstract Aims Iron deficiency (ID) is a frequent finding in patients with chronic and acute heart failure (AHF) along the full spectrum of left ventricular ejection fraction (LVEF). has been related to systolic dysfunction, but its role right function not evaluated. We sought evaluate whether ID identifies greater dysfunction setting AHF. Methods results prospectively included 903 admitted Right was evaluated by tricuspid annular plane excursion (TAPSE) ratio TAPSE/pulmonary artery pressure...

10.1093/ehjacc/zuaa028 article EN cc-by-nc European Heart Journal Acute Cardiovascular Care 2020-11-12

Heart failure with preserved ejection fraction (HFpEF) often coexists chronic kidney disease (CKD). Exercise intolerance is a major determinant of quality life and morbidity in both scenarios. We aimed to evaluate the associations between N-terminal pro-B-type natriuretic peptide (NT-proBNP) carbohydrate antigen 125 (CA125) maximal aerobic capacity (peak VO

10.1093/ckj/sfae199 article EN cc-by Clinical Kidney Journal 2024-07-02
Coming Soon ...